Efficacy of interferon alpha-2b and ribavirin against West Nile virus in vitro [3]

Emerging Infectious Diseases

Volumn 8, Issue 1, 2002, Pages 107-108

  Anderson, John F ^a   Rahal, James J ^a,b  

^a The Connecticut Agricultural Experiment Station   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT ALPHA2B INTERFERON; RIBAVIRIN;

ANIMAL CELL; ANTIVIRAL ACTIVITY; DOSE RESPONSE; DRUG EFFICACY; HUMAN; LETTER; NONHUMAN; VERO CELL; VIRUS INFECTION; WEST NILE FLAVIVIRUS;

EID: 0036151539     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid0801.010252     Document Type: Letter

References (10)

1. Guidelines for surveillance, prevention, and control of West Nile Virus infection - United States
2. Origin of the West Nile virus responsible for an outbreak of encephalitis in the Northeastern United States
3. Antiviral activity of Virazole on replication of viruses isolated in Nigeria
4. Ribavirin inhibits West Nile virus replication and cytopathic effect in neural cells
5. Different pathogenicity ofencephalitic togaviruses in organotypic cultures of spinal cord slices
6. Isolation of West Nile virus from mosquitoes, crows, and a Cooper's hawk in Connecticut
7. Ribavirin and interferon alpha 2-b in chronic hepatitis C: Assessment of possible pharmacokinetic and pharmacodynamic interaction
8. Ribavirin disposition in high risk patients for acquired immunodeficiency syndrome
9. Lassa fever. Effective therapy with ribavirin